]>
IRCT20190916044785N1 IRCT 2019-10-20 Hamedan University of Medical Sciences Evaluation of The Effect of Nanocurcumin on Treatment of Tinnitus Evaluation of The Effect of Nanocurcumin on Treatment of Tinnitus:A Triple Blinded Randomized Clinical Trial 2019-09-23 anticipated 62 Complete https://irct.ir/trial/42166 interventional Randomization: Randomized, Blinding: Triple blinded, Placebo: Used, Assignment: Parallel, Purpose: Treatment, Randomization description: We will write two letter Asheets and two letter B sheets. Mix the sheets together. We will place one in the drawer of the table. Each eligible patient will be randomly pulled out and given A or B drawn. It should be noted that these extruded sheets will not be returned to the drawer until all four sheets have been extracted. In the four sheets, all the sheets are returned to the drawer and the same procedure will continue for the next four patients until the desired sample size is reached, Blinding description: Drugs are excluded from the drug cover and given to the patient without the name of the drug in the envelopes containing Addicts A and B. Therefore, the patient will not be informed of the type of drug used. Therefore, the examining physician will not be aware of the type of drug used by the patients. The intervention and comparison groups will be coded and the data analyst will not be informed of the intervention type. Thus, the study will be conducted in a triple blind manner. 3 tinnitus. Intervention 1: The Intervention group will Consume Sina 80 mg Nano curcumin Supplement with Meals for 21 days . Intervention 2: Control group: The Control group will consume Placebo capsul once a day for 21 days. Capsuls are desigend in the same shape with curcumin. Yes - There is a plan to make this available What will be shared: The Information in the Article will be shared When: After preparing the Article To whom: Researchers Conditions: Be request Where to obtain: The request should be sent to the following Email: dr_f_farahani@yahoo.com How to obtain: The request should be sent to the following Email: dr_f_farahani@yahoo.com Comments:
public Zahra Farahani
Next to ENT Clinic, Besat Hospital, Hamadan, Iran
Hamadan Iran (Islamic Republic of) 6514845471 +98 81 3264 0021 Zfarahani93@ymail.com Hamedan University of Medical Sciences scientific Farhad Farahani
Next to ENT Clinic, Besat Hospital, Hamadan,Iran
Hamadan Iran (Islamic Republic of) 6514845471 +98 81 3264 0021 dr_f_farahani@yahoo.com Hamedan University of Medical Sciences Iran (Islamic Republic of) Unilateral or Bilateral Subjective Tinnitus Age Range: 18-65 Year Patients do not have Pregnancy and Breastfeeding Patients do not have Acute or Chronic Ear Infection Patients do not have Rheumatologic Diseases, Vasculitis, Acoustic Neuroma, Known Neurological Disorders and Ear Surgery Patients not taking Immunosuppressants such as Interferons, Corticosteroids, Anticonvulsants and Sedatives before starting the study 18 years 65 years Both Patients who do not willing to enter the study H93.1 Tinnitus Treatment - Drugs Placebo The Intervention group will Consume Sina 80 mg Nano curcumin Supplement with Meals for 21 days . Control group: The Control group will consume Placebo capsul once a day for 21 days. Capsuls are desigend in the same shape with curcumin. Tinnitus Handicap Inventory. Timepoint: Before and after 21 days of Medicine Consumption. Method of measurement: Tinitus Matching Test. Hamedan University of Medical Sciences Approved 2019-09-14 Ethics committee of Hamadan University of Medical Science Research and Technology Vice Chancellor, Hamadan University of Medical Sciences, In front of Mardom Park, Hamadan Hamadan Hamadan Iran (Islamic Republic of)